Close

HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference May 2, 2023 08:15AM
HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 Nov 21, 2022 09:00AM
Heart Test Laboratories, Inc. Announces Pricing of $6.375 Million Initial Public Offering and Nasdaq Listing Jun 15, 2022 09:50AM